{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:40:55Z","timestamp":1792503655131,"version":"4.5.0"},"reference-count":103,"publisher":"Informa UK Limited","issue":"10","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"Azurity Pharmaceuticals Inc"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2026,10,3]]},"DOI":"10.1080\/17474086.2026.2715450","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:39:37Z","timestamp":1786549177000},"page":"1179-1194","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Nilotinib in chronic myeloid leukemia: clinical value, real-world challenges, and the potential of nilotinib tablets to improve therapeutic outcomes"],"prefix":"10.1080","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6248-3317","authenticated-orcid":false,"given":"Kendra","family":"Sweet","sequence":"first","affiliation":[{"name":"University of South Florida Morsani College of Medicine, Moffitt Cancer Center, Magnolia Campus","place":["Tampa, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4899-3796","authenticated-orcid":false,"given":"Srinivas","family":"Tantravahi","sequence":"additional","affiliation":[{"name":"Huntsman Cancer Institute","place":["Salt Lake City, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paras","family":"Jain","sequence":"additional","affiliation":[{"name":"Azurity Pharmaceuticals Inc., Hyderabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3693-8864","authenticated-orcid":false,"given":"Dan","family":"Douer","sequence":"additional","affiliation":[{"name":"University of Southern California, Keck School of Medicine, LA General Medical Center","place":["Los Angeles, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13246269"},{"issue":"6","key":"e_1_3_5_4_1","first-page":"646","article-title":"Inhibidores de cinasas de tirosina (ICT): la nueva revoluci\u00f3n en el tratamiento de la leucemia mieloide cr\u00f3nica (LMC) [Tyrosine kinase inhibitors (TKI): a new revolution in the treatment of chronic myeloid leukemia (CML)]","volume":"149","author":"Avil\u00e9s-V\u00e1zquez S","year":"2013","unstructured":"Avil\u00e9s-V\u00e1zquez S, Ch\u00e1vez-Gonz\u00e1lez A, Mayani H. Inhibidores de cinasas de tirosina (ICT): la nueva revoluci\u00f3n en el tratamiento de la leucemia mieloide cr\u00f3nica (LMC) [Tyrosine kinase inhibitors (TKI): a new revolution in the treatment of chronic myeloid leukemia (CML)]. Gac Med Mex. 2013;149(6):646\u2013654. Spanish.","journal-title":"Gac Med Mex"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35953"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01736-5"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/20406207231216077"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers18121922"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1931.02730010007002"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0b013e31823dec8d"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2009.1.453"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.12.4064.bloodjournal84124064"},{"key":"e_1_3_5_13_1","volume-title":"StatPearls [Internet]","author":"Thomson RJ","year":"2026","unstructured":"Thomson RJ, Moshirfar M, Ronquillo Y. Tyrosine kinase inhibitors. In: StatPearls [Internet]. Treasure Island FL: StatPearls Publishing; 2026 Jan [updated 2023 Jul 18; cited 2026 Apr 14]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK563322\/"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2014.009"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13194820"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.2006-0638"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21380"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta16220"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2017.01.004"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.4103\/0976-500X.149141"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.2147\/BTT.S5775"},{"key":"e_1_3_5_22_1","unstructured":"TASIGNA (nilotinib) capsules for oral use. Novartis; 2024 [cited 2026 Apr 9] Available from: https:\/\/www.novartis.com\/us-en\/sites\/novartis_us\/files\/tasigna.pdf"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-020-02910-3"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)00080-2"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-025-02664-w"},{"key":"e_1_3_5_26_1","unstructured":"NCCN. Chronic myeloid leukemia. Version 1. 2026. 2025 Jul 16 [cited 2026 Apr 19]. p. 106. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cml.pdf"},{"key":"e_1_3_5_27_1","unstructured":"U.S. Food and Drug Administration. Drug approval package. 2008 [cited 2026 Apr 20] Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2007\/022068toc.cfm"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.5"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0912614"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-01111-2"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2025.287813"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-06-511592"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.8899"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-376087"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01589-y"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2400858"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025029210"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.70126"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01205-5"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-018-2604-x"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.280175"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.63"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01260-y"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18796"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2026020915"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-483750"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70233-3"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30235-2"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2019.1675879"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18883"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-208460"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-026-06806-7"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2025-7293"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27443"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-196543"},{"issue":"3","key":"e_1_3_5_56_1","first-page":"142","article-title":"Non-adherence to CML therapy and its clinical implications in India","volume":"30","author":"Menon H","year":"2017","unstructured":"Menon H. Non-adherence to CML therapy and its clinical implications in India. Natl Med J India. 2017;30(3):142\u2013147.","journal-title":"Natl Med J India"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000000700"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13030-023-00261-w"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S472478"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1159\/000345722"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.4184"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2021.158"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022009074"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2014.20.10.1006"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110847"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.3087"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V116.21.3414.3414"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1179\/1607845414Y.0000000165"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3971"},{"key":"e_1_3_5_70_1","unstructured":"GLEEVEC (imatinib mesylate) tablets for oral use. Novartis; 2007 [cited 2026 Jul 12] Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2007\/021588s020lbl.pdf"},{"key":"e_1_3_5_71_1","unstructured":"SPRYCEL (dasatinib) tablets for oral use. Bristol Myers Squibb; 2024 [cited 2026 Jul 12] Available from: https:\/\/packageinserts.bms.com\/pi\/pi_sprycel.pdf"},{"key":"e_1_3_5_72_1","unstructured":"BOSULIF (bosutinib) tablets for oral use. Pfizer; 2026 [cited 2026 Jul 12] Available from: https:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=884"},{"key":"e_1_3_5_73_1","unstructured":"SCEMBLIX (asciminib) tablets for oral use. Novartis; 2025 [cited 2026 Jul 12] Available from: https:\/\/www.novartis.com\/us-en\/sites\/novartis_us\/files\/scemblix.pdf"},{"key":"e_1_3_5_74_1","unstructured":"ICLUSIG (ponatinib) tablets for oral use. Takeda; 2025 [cited 2026 Jul 12] Available from: https:\/\/www.iclusig.com\/hcp\/sites\/default\/files\/2022-10\/ICLUSIG-Prescribing-Information.pdf"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-3-47"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1177\/1078155219827637"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2025-2833"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1177\/1078155216679026"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-11-167"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-025-04777-6"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-011-1200-7"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.058776"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13155"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S163393"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.5045\/br.2023.2023035"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-06-510396"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13092567"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.70000"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.70276"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2025-903"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-025-02592-9"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00665"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1159\/000548812"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.4103\/apjon.apjon_7_17"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-022-01274-0"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41687-018-0057-2"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S269355"},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35021"},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.1177\/15593258261454350"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2025.287766"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17132148"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024026310"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2025.115593"},{"key":"e_1_3_5_104_1","doi-asserted-by":"publisher","DOI":"10.1177\/10781552261423198"},{"key":"e_1_3_5_105_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-04045-y"}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2026.2715450","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/17474086.2026.2715450","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2026.2715450","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:02:01Z","timestamp":1792501321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474086.2026.2715450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":103,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,3]]}},"alternative-id":["10.1080\/17474086.2026.2715450"],"URL":"https:\/\/doi.org\/10.1080\/17474086.2026.2715450","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"value":"1747-4086","type":"print"},{"value":"1747-4094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-06-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}